EDGE
  • home.svg
    Home
  • news.svg
    All updates
  • news.svg
    EDGE Insights
  • list.svg
    Industries
  • db-search.svg
    Company Search
  • company-list.svg
    My Watchlists (Beta)

PhAST Diagnostics

Overview
PhAST Diagnostics develops an AI imaging technology for combating antibiotic resistance. Its cloud-based platform provides clinical decision support for doctors, workflow improvement for hospitals, and helps accelerate the drug development process for pharmaceutical companies.
HQ location:
Cambridge, MA
Founded year:
2017
Employees:
11-50
IPO status:
Private
Total funding:
USD 15.4 mn
Last Funding:
USD 4.4 mn (Series Unknown; Dec 2022)
Last valuation:
-
Funding data are powered by Crunchbase
About EDGE
Contact Us
Resources
SPEEDA EDGE logo

Technology Research Made Effortless

Get a demo
Terms & conditionsPrivacy policyDo not sell my personal information
SPEEDA Edge is owned by Uzabase, the business intelligence and media company. ©2024 Uzabase, Inc. and Uzabase USA, Inc. All rights reserved.
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.